Skip to main content
ILDONG HOLDINGS CO.,LTD logo

ILDONG HOLDINGS CO.,LTD — Investor Relations & Filings

Ticker · 000230 ISIN · KR7000230003 KO Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2023-03-16 Annual Report
Country KR South Korea
Listing KO 000230

About ILDONG HOLDINGS CO.,LTD

https://www.ildongholdings.com

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Recent filings

Filing Released Lang Actions
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the 80th fiscal year (2022) of Ildong Holdings. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K, serving as the comprehensive annual report that includes financial statements, business overview, governance, and management analysis. It is submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2022
2023-03-16 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Ildong Holdings. It contains the meeting agenda, details on board member elections, financial statement approval, and management reports. While it includes financial data, it is primarily a proxy solicitation document sent to shareholders to inform them of the upcoming meeting and request their votes on specific agenda items. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2023-03-09 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the AGM results, or a proxy statement, it falls under the general regulatory filing category.
2023-03-09 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Il-dong Holdings regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경(자회사의 주요경영사항)
Earnings Release Classification · 100% confidence The document is a regulatory filing from Ildong Holdings regarding a significant change in sales or profit/loss structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the fiscal year compared to the previous year. This is a standard Korean regulatory disclosure (DART system) for preliminary earnings, which falls under the 'Earnings Release' category as it provides key financial highlights before the final audited report. FY 2022
2023-02-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from Ildong Holdings announcing a significant change (over 30%) in revenue or profit structure. It provides preliminary financial results (sales, operating profit, net income) for the fiscal year compared to the previous year. This type of disclosure is a standard regulatory requirement in South Korea for listed companies to report material changes in financial performance before the final audit report is filed. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the change, while explicitly noting that it is preliminary and subject to audit. FY 2022
2023-02-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.